Xconomy: Acute Myeloid Leukemia News, Articles and Opinions

“acute-myeloid-leukemia” Archives

Entry	Author	Date	Location
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More	Frank Vinluan	05/17/19	National
TP Therapeutics Names New CEO, Gets $80M More for Cancer Drug Push	Sarah de Crescenzo	10/19/18	San Diego
Bio Roundup: CRISPR Advances, Obamacare Lives, FDA Nods & More	Ben Fidler	08/04/17	National
With FDA Nod, Agios, Celgene Get Speedy OK For Blood Cancer Drug	Ben Fidler	08/01/17	Boston
Dragonfly, Tyler Jacks’s Disney-Backed Startup, Gets $33M in Celgene Deal	Ben Fidler	06/12/17	Boston
Bio Roundup: NIH Precision Boost, AHCA to Senate, New Drugs & More	Ben Fidler	05/05/17	National
Seattle Genetics to Resume Leukemia Drug Trials After FDA Lifts Hold	Frank Vinluan	03/06/17	Seattle
Bellicum, Molecular Templates Granted $32M for Immuno-Oncology Work	David Holley	11/17/16	Texas
All In One Place: A New Immuno-Oncology Trial Resource	Alex Lash	10/19/16	National
Celgene Plots Speedy FDA Filing for Agios Blood Cancer Drug	Ben Fidler	09/07/16	Boston
More Gene Therapy Momentum as Startup Avrobio Grabs $25M From Atlas, SV	Ben Fidler	08/02/16	Boston
Syros Files For IPO to Push “Gene Control” Drugs Through First Trials	Ben Fidler	06/06/16	Boston
Celator Parlays Leukemia Drug Data into $1.5B Buyout From Jazz Pharma	Ben Fidler	05/31/16	New York
UW Health Surgeon’s Startup Expanding Software to Monitor Patients	Jeff Buchanan	05/27/16	Wisconsin
Tech Megatransfer: Merck Pays Harvard $20M For “Accelerated” Cancer Drugs	Ben Fidler	03/21/16	Boston
East Coast Bio Roundup: PCSK9 Battle, NYU Startups, Blueprint & More	Ben Fidler	03/17/16	Boston
Stanford Spins Out Immunotherapy Work Funded By CIRM’s Millions	Alex Lash	02/25/16	San Francisco
East Coast Biotech Roundup: Editas, Checkmate, Ovid & More	Ben Fidler	08/14/15	Boston
East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More	Ben Fidler	06/12/15	Boston
Celgene, Versant Shake Again, Cut $30M Deal For Toronto Biotech	Alex Lash	04/29/15	New York
After Raising $60M, Kura Oncology Renews Work on Shelved Cancer Drug	Bruce V. Bigelow	03/12/15	San Diego
East Coast Biotech Roundup: Hamburg, Merck, Annovation, WaVe & More	Ben Fidler	02/09/15	Boston
East Coast Biotech Roundup: Yumanity, Padlock, CAR-T Fever, & More	Ben Fidler	12/19/14	Boston
ASH Roundup: Immunotherapy Stars, Gene Therapy Leaps Ahead	Ben Fidler	12/11/14	San Francisco
At ASH, Sunesis Dices Data to Argue For “Failed” Leukemia Drug	Alex Lash	12/07/14	San Francisco
With New Data, Agios Plots Quick Turn into Key Late-Stage Trials	Ben Fidler	12/07/14	Boston
Texas Cancer Center Seeks to Speed Discovery with Applied Research	Angela Shah	12/03/14	Texas
East Coast Biotech Roundup: Agios, Vertex, Epizyme, Celldex, & More	Ben Fidler	11/21/14	Boston
Déjà Vu for Agios as Second Drug Shines in Small Blood Cancer Study	Ben Fidler	11/18/14	Boston
MD Anderson Showcases “Moon Shots” Progress in Fight Against Cancer	Angela Shah	11/03/14	Texas
Page 1 of 3	next page »